GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Novel Approaches to Targeting Cancers Associated with VHL Mutations

$789,660
Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS

$789,107
Joseph M Salvino · Alliance Discovery, Inc. · R44 · FY2018 · CA

Genetic Epidemiology of Cancer

$789,073
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2019 · HG

The NYU Women's Health Study

$788,279
Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2015 · CA

International Center of TCM for Cancer

$787,818
Lorenzo Cohen · University Of Tx Md Anderson Can Ctr · U19 · FY2006 · CA

Building protected data sharing networks to advance cancer risk assessment and treatment

$787,369
Ian Foster · University Of Chicago · U24 · FY2018 · CA

Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas

$787,123
Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA

Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas

$787,123
Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA

Altered metabolism and machine learning for pancreatic cancer early detection

$786,734
Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2024 · CA

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study

$786,628
Michael G. Goggins · Johns Hopkins University · U01 · FY2022 · CA

Fibroblast orchestration of the immune response in pancreatic cancer

$786,440
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2024 · CA

Advanced Mass Spectrometry Facility

$783,233
David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma

$782,691
Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2023 · CA

Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent

$782,502
Charite Nicolette Ricker · University Of Southern California · R01 · FY2023 · CA

Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA

$782,480
Vladimir P Torchilin · Northeastern University · U54 · FY2011 · CA

NanoCytology to mitigate overdiagnosis of prostate cancer

$782,124
Hariharan Subramanian · Nanocytomics, Llc · R44 · FY2017 · CA

Design And Development Of Experimental Therapeutics

$781,688
Nigel H. Greig · Aging · Z01 · FY2007 · AG

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$781,677
Shounak Majumder · Mayo Clinic Rochester · U01 · FY2023 · CA

Circulating Biomarker Consortium for Pancreatic Cancer Early Detection

$781,620
Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2020 · CA

Genetically-based neuro-modulation of adipose tissue functions

$781,440
Heike Muenzberg-Gruening · Lsu Pennington Biomedical Research Ctr · OT2 · FY2016 · OD

Fibroblast Heterogeneity in Pancreatic Cancer

$780,205
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2023 · CA

SPATIALLY RESOLVED MOLECULAR INTERROGATION OF PANCREATIC ADENOSQUAMOUS CANCER

$779,999
Oregon Health & Science University · · FY2025 · Defense Health Agency

Fibroblast Heterogeneity in Pancreatic Cancer

$779,963
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2022 · CA

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology

$779,609
Jennifer B Permuth · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA

Genetically-based neuro-modulation of adipose tissue functions

$779,522
Heike Muenzberg-Gruening · Lsu Pennington Biomedical Research Ctr · OT2 · FY2018 · OD